U.S. Markets open in 1 hr 53 mins

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7400+0.1700 (+10.83%)
At close: 1:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.59
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.0800
52 Week Low 30.7600
50-Day Moving Average 31.6832
200-Day Moving Average 32.7064

Share Statistics

Avg Vol (3 month) 3226.69k
Avg Vol (10 day) 3242.16k
Shares Outstanding 510.49M
Float 10.46M
% Held by Insiders 10.50%
% Held by Institutions 16.88%
Shares Short (Nov 12, 2020) 4290.42k
Short Ratio (Nov 12, 2020) 41.79
Short % of Float (Nov 12, 2020) 42.78%
Short % of Shares Outstanding (Nov 12, 2020) 42.77%
Shares Short (prior month Oct 14, 2020) 4172.65k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-57.96%
Return on Equity (ttm)-104.16%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.95M
Net Income Avi to Common (ttm)-12.96M
Diluted EPS (ttm)-1.3780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.11M
Total Cash Per Share (mrq)0.87
Total Debt (mrq)31.28k
Total Debt/Equity (mrq)0.32
Current Ratio (mrq)7.23
Book Value Per Share (mrq)0.88

Cash Flow Statement

Operating Cash Flow (ttm)-10.85M
Levered Free Cash Flow (ttm)-6.02M